4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the Food and Drug Administration in the past week.

  1. Kalydeco may now be used to treat patients with 33 genetic mutations associated with cystic fibrosis. The FDA originally approved the drug to treat 10 disease mutations.

  1. MindMotion Pro is a neuro-technology platform that uses virtual reality to aid in stroke patients' rehabilitation.

  1. Clofarabine is intended to treat pediatric patients 21 years and younger with acute lymphoblastic leukemia who've previously received at least two other treatments.

  1. Levocetirizine dihydrochloride is a generic treatment used to relieve symptoms associated with perennial allergic rhinitis in children two years old and younger.

More articles on supply chain: 

Top 5 retail pharmacy chains by store count
The Hospital Supply Chain: Where You Sit Changes Everything
Supply chain tip of the day: Reducing supply fee structures

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months